Isoniazid activity is terminated by bacterial persistence.
Mitchison
Denis A
DA
Jindani
Amina
A
Davies
Geraint R
GR
Sirgel
Frederik
F
D000995:Antitubercular Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000502:physiology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D008954:Models, Biological; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000502:physiology; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D007538:Isoniazid